Evidence map›Paper›PMID 30613008›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2018

[Expression of miR-454-3p and its effect on proliferation, invasion and metastasis of colon cancer].

Wenhua Li, Yun Feng, Zhenzeng Ma, Lungen Lu

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. [Silenced ANP32A inhibits the growth, invasion and migration of colorectal cancerNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  2. Tumor Suppressor 4.1N/Frontiers in genetics · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wenhua LiDepartment of Gastroenterology, Shanghai General Hospital of Nanjing Medical University, Shanghai 201600, China.
Yun FengDepartment of Gastroenterology, Shanghai General Hospital of Nanjing Medical University, Shanghai 201600, China.
Zhenzeng MaDepartment of Gastroenterology, Shanghai General Hospital of Nanjing Medical University, Shanghai 201600, China.
Lungen LuDepartment of Gastroenterology, Shanghai General Hospital of Nanjing Medical University, Shanghai 201600, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study the expression of miR-454-3p in colon cancer and its effect on colon cancer proliferation, invasion and hepatic metastasis.

methodsSpecimens of tumor tissues and paired adjacent tissues were collected from 20 patients with colorectal cancer for detecting the expression levels of miR-454-3p using in situ hybridization. Colon cancer cell line SW480 was transfected with a lentiviral vector to induce miR-454-3p over-expression, and the changes in cell proliferation and invasion were observed using cell counting kit-8 (CCK-8), clone formation assay and Transwell experiment. The effect of miR- 454-3p over-expression on hepatic metastasis of colon cancer was assessed in BALB/c mouse models.

resultsThe results of in situ hybridization showed a significantly increased expression level of miR-454-3p in colon cancer tissues as compared with normal colon tissues (

conclusionsmiR-454-3p is overexpressed in the tumor tissues in patients with colorectal cancer and participates in the progression of colorectal cancer by promoting cancer cell proliferation, invasion, and liver metastasis. miR-454-3p may serve as a novel biomarker for colorectal cancer diagnosis and prognostic evaluation.

Indexed as

Cell MovementCell ProliferationAnimalsBiomarkers, TumorCell Line, TumorColonColonic NeoplasmsDisease ProgressionHumansLiver NeoplasmsMiceMice, Inbred BALB CMicroRNAsNeoplasm InvasivenessBiomarkers, TumorMicroRNAsMIRN454 microRNA, humancolon cancerinvasionmetastasismicroRNA

Identifiers

PMID30613008
PMCPMC6744220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.